MedTrace Logo

Usability of Pericardial Flushing with the Haermonics Pure System After Cardiac Surgery

NCT06521164 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2025-03-14

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the usability of the Haermonics Pure system in patients undergoing a cardiac surgery procedure with the use of cardiopulmonary bypass.

All measurements and interventions are standard of care, except pericardial flushing with the Haermonics Pure system.

Conditions

  • Surgical Blood Loss
  • Surgical Complication

Interventions

DEVICE

Haermonics Pure system

pericardial flushing with Haermonics Pure system

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Haermonics BV

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-05-31
Completion
2026-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06521164 on ClinicalTrials.gov